More Expensive Healthcare is Coming...
Pharmaceutical companies are attempting to eliminate a federal program that costs taxpayers nothing and replace it with a system where everyone in America would be burdened with increased medical costs, higher taxes, and worse healthcare outcomes.
All of this to pad the pockets of pharmaceutical executives and their shareholders.
How Can You Stop Them?
The best way you can make an impact is by reaching out to your local and federal representatives and telling them to leave the 340B Drug Pricing Program alone.
We need everyone to come together and tell pharmaceutical companies enough is enough. They have shifted enough money into executives and investors pockets at the expense of our healthcare.
The time to act is now - fill out the form below and let your representative know that the 340B Drug Pricing Program is important and saves lives.
What is the 340B Drug Pricing Program?
The 340B Drug Pricing Program was created in 1992 and allows qualifying hospitals and clinics that serve low-income and uninsured patients to buy prescription drugs at a discount. The idea behind the program was to create a way for safety-net health care providers to offer life saving services to their patients without taxpayer funding.
Pharmaceutical companies agreed and enthusiastically signed onto this program because in return the government allowed them to participate in the Medicaid program - opening them up to an extremely lucrative, government funded, healthcare market.
To give you an example of how lucrative this arrangement has been, Medicaid paid out $210.6 billion in tax payer money to pharmaceutical companies for medications in 2021.
How Does the 340B Drug Pricing Program Work?
The 340B Drug Pricing Program is a very simple program in action.
Pharmaceutical companies provide qualifying medical facilities that serve low-income and uninsured patients’ medications at a 25% to 50% discounts. These clinics are then reimbursed the full amount by insurance companies.
340B entities take the savings from the discounted medication and pass it onto under or uninsured individuals and provide them their life saving medication at no cost to them.
The 340B program saves people’s lives every day, and pharmaceutical companies want to end it so they can provide more money for their executives and shareholders at the expense of vulnerable individuals who would suffer without this program.
